3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
10
Neoplasms
7
Motor Activity
5
Rectal Neoplasms
3
Pain, Postoperative
3
Vomiting
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Nausea
2
Lung Neoplasms
2
Liver Diseases
2
Leukemia, Myeloid, Acute
2
Fatigue
2
Colorectal Neoplasms
2
Agnosia
2
Uterine Cervical Neoplasms
1
Ulcer
1
Stomatitis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Initiation and Maintenance Disorders
1
Postoperative Cognitive Complications
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Pediatric Brain Tumor
1
Pathologic Processes
1
Papillomavirus Infections
1
Pain
1
Osteolysis
1
Multiple Myeloma
1
Malnutrition
1
Interventions
Gemcitabine
32
Cisplatin
31
durvalumab
15
pembrolizumab
14
Fluorouracil
13
Oxaliplatin
12
Leucovorin
12
Capecitabine
10
Bevacizumab
8
lenvatinib
7
Nivolumab
7
zanidatamab
4
Trastuzumab
4
S 1 (combination)
4
Paclitaxel
4
Liquid Biopsy
4
Irinotecan
4
Carboplatin
4
Albumin-Bound Paclitaxel
4
tremelimumab
3
tislelizumab
3
irinotecan sucrosofate
3
Injections
3
Folfox protocol
3
130-nm albumin-bound paclitaxel
3
toripalimab
2
pertuzumab
2
niraparib
2
ivosidenib
2
envafolimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
Control Groups
×
1 year
×
Clear all
No trials found.